digital health companies weight loss glp-1 Miami's eMed just hit a $2 billion valuation—and Tom Brady is now its chief wellness officer. The company raised $200 million in series A funding to advance its AI-powered platform glp-1 digital health platform startups

Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in some studies, with weight reductions of approximately 20% in the SURMOUNT-1 trial

These figures are averages and individual results may vary depending on diet, physical activity, insulin resistance, and overall health

This small protein, produced naturally in the body, maintains these three crucial protective functions

Studied in preclinical models for its role in metabolic and mitochondrial biology research

10.1016/j.ccr.2006.08.015 Cancer Cell 164 SenaL